Ziopharm's Pause On Its Phase 3 Brain Cancer Study Is More Valuable Than You Think [Seeking Alpha]
ARMO BIOSCIENCES (ARMO)
US:NASDAQ Investor Relations:
armobio.com
Company Research
Source: Seeking Alpha
Ziopharm's Pause On Its Phase 3 Brain Cancer Study Is More Valuable Than You ThinkSummaryZiopharm Oncology announced that the phase 3 trial using Ad-RTS-hIL-12 plus veledimex to treat patients with recurrent glioblastoma had been paused.A better synergistic opportunity exists to treat patients with recurrent glioblastoma by combining Ad-RTS-hIL-12 plus veledimex with checkpoint inhibitors.A trial is underway combining Ad-RTS-hIL-12 plus veledimex with Opdivo to improve clinical outcomes for patients with recurrent glioblastoma.The acquisition by Eli Lilly for Armo BioSciences totaling $1.6 billion proves how valuable cytokine biotechs may become when being incorporated with other checkpoint inhibitors.Ziopharm Oncology will be okay in the long term because it is even developing its own CAR-T pipeline.
Show less
Read more
Impact Snapshot
Event Time:
ARMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARMO alerts
High impacting ARMO BIOSCIENCES news events
Weekly update
A roundup of the hottest topics